Rubio MD, Haroutunian V, Meador-Woodruff JH: Dysfunction of the Ubiquitin Proteasome and Ubiquitin-Like Systems in Schizophrenia. Neuropsychopharmacology. In press.

Gamble, K.L. and Young, M.E. (2013). Metabolism as an Integral Cog in the Mammalian Circadian Clockwork.Crit Rev Biochem Mol Biol, 48(4):317-31.

Drummond JB, Tucholski J, Haroutunian V, Meador-Woodruff JH: Transmembrane AMPA Receptor Regulatory Protein (TARP) Dysregulation in Anterior Cingulate Cortex in Schizophrenia.  Schizophrenia Research. In press.

Kathy B. Avsar, James E. Cox, Rosalyn E. Weller, Meredith Reid, David White, Adrienne C. Lahti. An fMRI investigation of temporal discounting in patients with schizophrenia. In Press, Brain and Behavior.

  • Mark S Bolding, David M White, Jennifer A Hadley, Martin Weiler, Henry H Holcomb, and Adrienne C Lahti. Antipsychotic drugs altered functional connectivity between medial frontal cortex, hippocampus, and ventral striatum. Frontiers in Psychiatry, 3: 105, 2012.
Callahan, S.T., Fuchs D.C., Shelton R.C., Balmer L.S., Dudley J.A., Gideon P.S., DeRanieri M.M., Stratton S.M, Williams C.L., Ray W.A., Cooper W.O. Identifying suicidal behavior among adolescents using administrative claims data. Pharmacoepidemiology and Drug Safety 22:769-775, 2013.

  • Tucholski J, Simmons MS, Pinner AL, Haroutunian V, McCullumsmith RE, and Meador-Woodruff JH:  Abnormal N-linked Glycosylation of Cortical AMPA Receptor Subunits in Schizophrenia.  Schizophrenia Research. In press

Nierenberg A.A., Kansky C., Brennan B.P., Shelton R.C., Perlis R., Iosifescu D.V. Mitochondrial modulators for bipolar disorder: A pathophysiologically informed paradigm for new drug development. Australian and New Zealand Journal of Psychiatry 47:26-42, 2012

Papakostas G.I., Vitolo O.V., Ishak W.W., Rapaport M.H., Zajecka J.M., Kinrys G., Mishoulon D., Lipkin S.H., Abrams J., Ward S.G., Meisner A., Schoenfeld D.A., Shelton R.C., Winokur A., Okasha M.S., Bari M.A., Fava M. A 12-week, randomized, double-blind, placebo-controlled, parallel-sequential trial of ziprasidone as monotherapy for major depressive disorder. J. Clin Psychiatry 73:1541–1547, 2012

Rowse, A., L., Naves, R., Cashman, K., S., McGuire, D.J., Mbana, T., Raman, C., and De Sarno, P*., 2012. Lithium controls Central Nervous System autoimmunity through regulation of IFNγ signaling. PLoS One, 7(12): e52658. Epub 2012 Dec 28.